Relation between physicians and pharmaceutical industry is required for the benefit of the patient. But it may turn into business and overthrow the patients' benefit. The relation might be in question at present and in future.
2
The promotion of medicines is very influential and needs to be carefully controlled. The pharmaceutical industry differs from other industries in that its products directly affect the health of patients. The sale of these medicines is strictly controlled through market authorization (registration), prescribing and dispensing regulations. Ethical promotion of medicines is important in order to ensure that medicines are prescribed and used in a rational way.
Promotional activities that do not comply with ethical criteria for medicinal pharmaceutical promotion are an important factor contributing to inappropriate overuse and unnecessary costs 3 
.
In the world, the rise of the pharmaceutical industry's importance as a funder of mainstream research and education is increasing. Approximately 60 percent of biomedical research and development today is funded by industries 4, 5 .
Pharmaceutical companies' share of funding for clinical trials is more than 70 percent 6, 7 . The industry also shoulders more than half of the costs of continuing medical education 8, 9 . Financial entanglement has bred close ties between the industry and physicians. There is hardly a physician practicing today who has not been the beneficiary of small "educational" gifts such as pens and memo pads or lunch for the office staff 10 . Many physicians attend dinners to hear a hired expert talk about a product, take educational trips to resorts, or receive funds in the form of research grants, trainee support, or lucrative consulting fees 11, 12 . These benefits are defended as a way to provide useful information for physicians as they address difficult problems in treating their patients. But at what point does the influence become corrosive to the good of the patient . "The Code provides that payment by or to a physician solely for the referral of a patient is unethical as is the acceptance by a physician of payment of any kind, and in any form, from any source such as a pharmaceutical company or pharmacist". Indian Medical Council Act strictly prohibit this 22 . In USA it is considered as criminal activity and prosecuted by fraud and abuse law 23 . b. Gifts provided by pharmaceutical company: Gifts are frequently supplied by medical representatives or at events to health-care professionals. Ethical criteria for medicinal drug promotion (WHO-ECPM) mentioned "Gifts offered to members of the medical and allied professions should be secondary to the purpose of the meeting and should be kept to a modest level" 24 .The code analysis demonstrates that some gifts are permitted under strict circumstances. The benefit for the profession or the opportunity for education of the health-care professional plays a key role in the permission of gifts. Apart from the permission of the supply of medical utilities or small gifts for the benefit of the health profession by the various codes, some offers with regard to hospitality are permitted. In the various national codes, requirements should be included to ensure that nothing be offered that would interfere with the independence of the health-care professional's prescribing or dispensing practices. The Association of the British Pharmaceutical Industry (ABPI) permits the supply of promotional aids to health professionals as long as these are inexpensive and relevant to the practice of the recipient's work. The ABPI also mentions a maximum cost of a utility, being six pounds 25 . Utilities for use by patients are also permitted. The ABPI requires that non professional gifts or other material or financial benefits should not be offered to healthcare professionals or administrative staff in order to induce them to prescribe, supply, administer, recommend, buy or sell any medicine 26 . c. Sample of Drug: According to Organization of Pharmaceutical Producer of India (OPPI) free samples of a pharmaceutical product may be supplied to healthcare professionals or to persons duly authorised by them who are qualified to prescribe such products in order to enhance patient care. Drug samples should not be resold or otherwise misused. 26 Irish Medical Council further clarifies that the number of such samples of each product that may be supplied to any one recipient in any one year shall be limited; the supply of any such sample is made only in response to a written request, signed and dated, by the recipient; each such sample is marked "free medical sample -not for sale" or words to the like effect for travel, lodging, and meal expenses; must be "genuine" services, not "token". Physicians may accept gifts at the conference from pharmaceutical companies under the following conditions: The gift must be primarily for the benefit of patients and be primarily related to the physician's work. The gift must be of insubstantial value and must not be cash. Drug samples permitted for physicians; personal and family use of the samples also permitted, provided that it does not interfere with patient access to the samples. 13 These criteria are also supported in UK and Ireland 25, 27 . 
Implementation

Conclusion:
The relationship between physician and pharmaceutical industry requires excellent ethical value. It might be in question at present and in future. In developed countries and our neighbor country had establish and published their status. A practice guideline is essential for Bangladesh regarding this issue. Professional organization and pharmaceutical association could take the initiative to reflect the transparency of relationship.
